Cell Signaling and Signal Transduction

Signal Transduction Overview

Part 1 of 7 — Signal Transduction Overview

A liver cell cannot see a predator, and a muscle cell cannot hear an alarm. Yet within seconds of a fright, your liver is dumping glucose into the blood and your heart is beating harder. Every one of those responses depends on cell communication: one cell releases a chemical message, and another cell detects it and changes what it is doing.

Cell signaling is not just an animal feature. Bacteria sense how crowded they are, yeast cells find mating partners, and plant cells coordinate defenses, all by detecting chemical signals. AP Biology treats signaling as one of the core ways cells interact with their environment and with each other (Unit 4, Topics 4.1–4.4).

The vocabulary you need from day one

🔑 Key Concept: The ligand itself usually does not do the work inside the cell. It carries information, not energy or raw material. The receptor and the proteins downstream of it do the work.

The three stages: reception → transduction → response

Almost every signaling pathway on the AP exam can be described in three stages.

1. Reception. The ligand binds the receptor's binding site. Binding is like a key in a lock: it depends on shape and chemical complementarity, and it is reversible.
2. Transduction. Ligand binding changes the receptor's shape (conformation). That shape change starts a series of changes in other molecules, a relay. Relay molecules are often proteins that are switched on by having a phosphate added, plus small molecules called second messengers.
3. Response. The last relay molecule changes something the cell does: it activates an enzyme, opens a channel, rearranges the cytoskeleton, or turns genes on or off.

Why have a middle stage at all? Transduction is where the cell gains control. Each step can amplify the signal (one active enzyme activates many molecules of the next), can be regulated by other inputs, and can branch so one signal triggers several responses. You will study each of these in Parts 3–5.

Check Your Understanding 🎯

A classic case: how epinephrine releases glucose

In the 1950s, Earl Sutherland studied how the hormone epinephrine (adrenaline) makes liver cells break down glycogen into glucose. His experiments show why the three-stage model matters.

Observation 1. Epinephrine added to intact liver cells activated the enzyme glycogen phosphorylase, which breaks glycogen down.

Observation 2. Epinephrine added to a test tube containing only the purified enzyme and glycogen did nothing.

Observation 3. When liver cells were broken open, epinephrine worked only if the plasma membrane fraction was present. The membrane fraction produced a small molecule, later identified as cyclic AMP (cAMP), and adding cAMP alone to the cytoplasm activated the enzyme even without epinephrine.

Interpretation, stage by stage:

📝 AP Connection: This is exactly the kind of experiment the AP exam describes and asks you to interpret. Ask three questions of any signaling data: Where is the receptor? What carries the signal inside? What is the measurable response?

Specificity: same body, different responses

Specificity has two layers.

1. Which cells respond depends on which receptors a cell makes. All your cells have the same genes, but each cell type expresses a different set of receptor genes.
2. How a cell responds depends on the relay proteins and target proteins it has. The same ligand can produce different responses in different cells.

The ligand is the same in all three rows. The difference lies in the receptor type and the downstream proteins each cell expresses.

💡 Misconception alert: "The signal tells the cell what to do." It is more accurate to say the signal selects a response the cell is already equipped to make. A cell can only respond with proteins it already has or can make from its own genes.

Apply It: Sutherland's Experiments 🔬

Roadmap for this topic

🎯 Takeaway: Signal → receptor (shape change) → relay → response. If you can name each stage and say what would happen if it were blocked, you can handle most AP signaling questions.

Match Each Event to Its Stage 🔍

Types of Signaling

Part 2 of 7 — Types of Signaling

Part 1 showed that every pathway runs reception → transduction → response. This part asks a different question: how does the signal get from the sending cell to the target cell? The AP CED sorts cell communication by distance:

Distance matters because it controls who receives the message, how fast it arrives and how long the effect lasts.

1. Direct contact

a. Cell junctions that connect cytoplasm

• Gap junctions (animals) are protein channels linking two cells. Ions and small molecules such as cAMP pass directly from one cell to the next. Heart muscle cells use gap junctions so that an electrical signal spreads quickly and the cells contract together.
• Plasmodesmata (plants) are channels through the cell walls lined with plasma membrane. Water, sugars, ions and even some RNA and proteins move from cell to cell.

b. Cell-surface recognition

Some signals are never released at all. A molecule anchored on one cell's surface binds a receptor on a neighbor's surface.

• Immune cells. An antigen-presenting cell displays a fragment of a pathogen on its surface. A helper T cell whose receptor matches that fragment binds it by direct contact and becomes activated. Cytotoxic (killer) T cells likewise recognize infected cells by contact before destroying them.
• Embryonic development. Neighboring cells touch and signal so that one becomes, for example, a nerve cell while the cell next to it becomes skin.

💡 Contact signaling is the most targeted form: only the cell actually touching receives the message.

Check Your Understanding 🎯

2. Local signaling: local regulators

A local regulator is secreted into the extracellular fluid and acts on cells nearby. It is quickly taken up, broken down or diluted, so its effect stays local.

Quorum sensing in bacteria. Bacteria use local signaling to measure their own population density. Each cell releases a small signal molecule (an autoinducer) at a low, steady rate. When few cells are present, the signal diffuses away. When the population is dense, the signal accumulates past a threshold, binds receptors in every cell, and switches on a set of genes all at once.

Example: the marine bacterium Vibrio fischeri glows only at high density, inside the light organ of the Hawaiian bobtail squid. A single free-living cell does not waste energy making light that would never be seen.

📝 AP Connection: Quorum sensing is the CED's model for how a signal can coordinate a group response. Biofilm formation and the release of toxins by some pathogens are also controlled this way.

3. Long-distance signaling: hormones

In endocrine signaling, specialized cells release hormones into the blood. The hormone reaches nearly every cell, but only cells with the matching receptor respond.

Plants also signal over long distances: hormones such as ethylene (fruit ripening) and auxin (growth toward light) move through tissues or the air.

Comparing the three categories

💡 Misconception alert: Nerve signals are not "long-distance hormone signals." A neuron's electrical impulse travels a long way along the axon, but the chemical signal at the end is local: the neurotransmitter crosses only a tiny synapse.

Apply It: Choosing the Signaling Type 🔬

Signaling is ancient: evidence from yeast

Baker's yeast (Saccharomyces cerevisiae) has two mating types, a and α. Each type secretes a mating factor that binds a receptor on cells of the other type. The receptor activates a G protein and then a chain of protein kinases, and the two cells grow toward each other and fuse.

The yeast receptor belongs to the same family (G protein-coupled receptors) that detects epinephrine, odors and light in animals, and the yeast kinase chain resembles the growth pathways in your own cells.

Why this matters: shared pathway parts in yeast, plants and animals suggest that these signaling systems evolved in an early common ancestor of eukaryotes and have been conserved.

🎯 Takeaway: Classify a signal by how it reaches the target: contact, local regulator or hormone. Then predict reach, speed and duration from that classification.

Classify Each Signal 🔍

Signal Reception

Part 3 of 7 — Signal Reception

Reception is the moment a ligand binds its receptor. It decides which cells respond and what kind of transduction follows. Two ideas from the CED organize this part:

1. A receptor's ligand-binding domain recognizes one specific chemical messenger (a peptide, a small molecule or a protein), in a highly specific fit.
2. Binding changes the receptor's shape, and that change, not the ligand entering the cell, is what passes the signal on.

Where is the receptor? Let the ligand's chemistry decide

The plasma membrane has a hydrophobic interior. That single fact predicts where a receptor must be.

Three families of membrane receptors

1. G protein-coupled receptors (GPCRs)

• A membrane protein with its ligand-binding domain facing outside the cell.
• Inside the cell it works with a G protein, a switch protein that is off when GDP is bound and on when GTP is bound.
• Ligand binding changes the receptor's shape, so the receptor makes the G protein swap GDP for GTP. The active G protein then moves along the membrane and activates an enzyme (for example, the enzyme that makes cAMP).
• The G protein turns itself off by hydrolyzing its GTP back to GDP, so the signal is temporary.
• GPCRs detect epinephrine, many neurotransmitters, odors and light. The CED uses them as its example of a eukaryotic receptor.

2. Receptor tyrosine kinases (RTKs)

• The receptor itself is an enzyme: when the ligand binds, its inside portion adds phosphate groups to proteins, starting a phosphorylation cascade.
• The insulin receptor and many growth-factor receptors are of this type. A faulty receptor that signals even without its ligand can drive uncontrolled cell division.
• The step-by-step activation mechanism of RTKs is not tested on the AP exam; know them only as another class of membrane receptor.

3. Ligand-gated ion channels

• A channel protein with a gate that opens (or closes) when the ligand binds.
• Ions such as Na⁺, K⁺, Ca²⁺ or Cl⁻ then flow down their gradients, changing the cell's membrane potential within milliseconds.
• Example: acetylcholine binding a channel on a skeletal muscle cell lets Na⁺ rush in, starting contraction.

Check Your Understanding 🎯

Intracellular receptors: when the receptor is a transcription factor

Steroid and thyroid hormones are hydrophobic enough to diffuse through the plasma membrane. Their receptors wait in the cytoplasm or nucleus.

Worked example: testosterone in a target cell

1. Testosterone, a steroid made from cholesterol, travels in the blood bound to carrier proteins.
2. It diffuses across the plasma membrane of every cell it reaches.
3. Only target cells contain the testosterone receptor. Binding changes the receptor's shape and activates it.
4. The hormone-receptor complex enters the nucleus (if it is not already there).
5. The complex acts as a transcription factor: it binds specific DNA sequences and turns on particular genes.
6. The new mRNAs are translated into proteins that produce the male characteristics the hormone controls.

💡 Misconception alert: Hydrophobic hormones enter all cells, not just target cells. Specificity still comes from the receptor: a cell without the intracellular receptor lets the hormone pass through and does nothing.

One ligand, different receptors

Some ligands have more than one receptor type, and the receptor type decides the response.

So "acetylcholine excites" or "acetylcholine inhibits" are both incomplete statements. The receptor, not the ligand, sets the meaning.

📝 AP Connection: A common free-response prompt gives a ligand's chemical structure or solubility and asks you to predict the receptor's location and justify the prediction. Use the membrane's hydrophobic core in your justification.

Apply It: Predicting Reception 🔬

Match the Receptor to the Description 🔍

Signal Transduction Pathways

Part 4 of 7 — Signal Transduction Pathways

Between the receptor and the response lies a signaling cascade: a chain of molecules, each one switching on the next. The CED stresses three things about cascades:

1. They relay the signal from the receptor to its targets inside the cell.
2. They often amplify the signal, so a few ligand molecules produce a large response.
3. Many of them work through protein modification, above all phosphorylation, and through small second messengers.

This part builds the cascade one molecule at a time, then follows the full epinephrine pathway from Part 1.

Phosphorylation cascades: switching proteins on and off

A protein kinase is an enzyme that transfers a phosphate group from ATP to another protein. The added phosphate carries negative charge, so it changes the target protein's shape, and with it the protein's activity.

In a phosphorylation cascade, kinase 1 phosphorylates and activates kinase 2, which activates kinase 3, and so on, until the final kinase phosphorylates the target protein that produces the response.

Why use a chain instead of a single step?

• Amplification: each active kinase phosphorylates many copies of the next kinase.
• Control points: each step can be sped up or blocked by other signals.
• Reversibility: phosphatases can switch every step off as soon as the ligand is gone, so the cell responds to the current level of signal.

💡 Misconception alert: Phosphorylation does not "give the protein energy." It changes the protein's shape, and shape determines function.

Second messengers

The ligand is the "first messenger." A second messenger is a small, non-protein molecule or ion that spreads quickly through the cytoplasm and carries the signal onward.

Cyclic AMP (cAMP) is the CED's model second messenger:

• An enzyme in the plasma membrane, switched on by the active G protein, converts ATP → cAMP.
• Many cAMP molecules spread through the cytoplasm and activate a protein kinase, which starts a phosphorylation cascade.
• The cAMP signal is short-lived: another cytoplasmic enzyme quickly breaks cAMP down to inactive AMP. The cAMP level therefore stays high only while the receptor keeps being stimulated.

📝 AP Connection: Know the sequence ligand → GPCR → G protein → cAMP-making enzyme → cAMP → protein kinase cascade → response, and be ready to predict what happens if any link is removed or stuck "on." The names of the individual enzymes and kinases in a pathway are not tested on the AP exam.

Check Your Understanding 🎯

Worked example: the epinephrine pathway in a liver cell, step by step

How it switches off: epinephrine leaves the receptor; the G protein hydrolyzes GTP; an enzyme breaks cAMP down; phosphatases remove the phosphates. Every "on" step has a matching "off" step.

Amplification in numbers

Suppose (with simplified, illustrative numbers) that:

• 1 active receptor activates 10 G proteins, each of which activates one cAMP-making enzyme,
• each of those enzymes makes 100 cAMP molecules,
• every cAMP leads to one active first kinase, and each first kinase activates 10 second kinases,
• each second kinase activates 10 glycogen-breaking enzymes.

Then one epinephrine molecule yields:

$1 \times 10 \times 100 \times 10 \times 10 = 10^5 \text{ active glycogen-breaking enzymes}$

Each of those enzymes then releases many glucose units per second, so the final output can reach the order of $10^8$ glucose molecules. This is why a tiny concentration of hormone in the blood can change the behavior of an entire organ.

Amplification Practice 🧮

A hypothetical cascade works like this: one active receptor activates 5 G proteins; each G protein activates 1 cAMP-making enzyme; each of those enzymes makes 200 cAMP; each cAMP activates 1 protein kinase; and each kinase activates 20 target enzymes.

1) How many cAMP molecules are made per active receptor? 2) How many target enzymes are activated per active receptor? 3) A drug halves the number of cAMP made by each cAMP-making enzyme. How many target enzymes are now activated per receptor?

Pathways branch and connect

Real cells do not run one isolated chain. Two features matter for the exam:

• Branching (divergence): one pathway can activate several targets. In the liver, a kinase in the epinephrine pathway both activates glycogen breakdown and inactivates glycogen synthesis, so the cell does not build glycogen while breaking it down.
• Cross-talk (convergence): two different signals can feed into the same relay molecule, and one pathway can block another. The cell's response reflects all the signals it receives at once.

🎯 Takeaway: In any cascade, ask what turns each step on, what turns it off, and how many molecules each step activates. Those three questions let you predict amplification, duration and the effect of any drug or mutation.

Apply It: Reading the Cascade 🔬

Name the Role 🔍

Cellular Responses

Part 5 of 7 — Cellular Responses

A pathway exists to change what the cell does. The CED states that signal transduction may change gene expression and cell function, which can alter the phenotype, or can lead to programmed cell death (apoptosis). It also asks you to explain how a change in any part of a pathway changes the response (Topic 4.3). This part covers both halves.

Where the response happens

Four kinds of response to know

1. Changes in enzyme or channel activity. The final relay protein activates or inhibits an existing protein. Example: the enzyme that breaks down glycogen is switched on and glucose is released.

2. Changes in gene expression. The pathway activates a transcription factor, which turns specific genes on or off. The DNA sequence is not changed; the cell simply makes different mRNAs and proteins.

• Plants: the gas ethylene triggers a pathway that turns on genes for enzymes that soften fruit and convert starch to sugar, so the fruit ripens.
• Seeds: the hormone gibberellin turns on genes for enzymes that break down stored starch, so a germinating seed can feed the embryo.
• Animal development: signals switch on HOX genes, which set up the body plan along the head-to-tail axis.

3. Cell division. Growth factors bind receptors (often receptor tyrosine kinases) and start pathways that push the cell past the G₁ checkpoint into the cell cycle.

4. Apoptosis (programmed cell death). Signals activate enzymes that dismantle the cell from the inside in a tidy, controlled way. Neighboring cells engulf the pieces without inflammation.

• During human development, apoptosis removes the tissue between the fingers and toes.
• Cells with severe DNA damage can be triggered to undergo apoptosis, protecting the body from cancer.

💡 Misconception alert: Apoptosis is not the same as cell death from injury (necrosis). Apoptosis is a response to a signal, built into normal development and maintenance.

Check Your Understanding 🎯

When a pathway changes: mutations

Any component can be altered: the receptor's binding domain, the receptor's intracellular domain, a relay protein, a second-messenger enzyme or the final target. Use one rule:

A change at one step affects every step downstream of it, and none of the steps upstream.

Then decide whether the change makes the component stuck off (loss of function) or stuck on (gain of function).

Case: a stuck relay protein and cancer. Many growth-factor pathways include a small relay G protein. Like other G proteins it is active with GTP bound and turns itself off by hydrolyzing GTP. Certain mutations stop it from hydrolyzing GTP, so it stays on and sends a constant "divide" signal even when no growth factor is present. Mutations of this kind are found in many human cancers.

Case: type 2 diabetes. Insulin is present, but target cells respond weakly because of problems in the receptor or the pathway downstream of it. Glucose uptake stays low, so blood glucose stays high. (In type 1 diabetes, by contrast, the signal itself is missing because insulin-producing cells were destroyed.)

When a pathway changes: chemicals, toxins and drugs

The CED notes that chemicals that interfere with any component can activate or inhibit the pathway.

A chemical that blocks a receptor without activating it is an antagonist. One that binds and activates the receptor in place of the natural ligand is an agonist.

📝 AP Connection: Signaling also sits inside larger feedback loops that keep body conditions stable; those loops are covered in the Feedback Mechanisms topic. Here, focus on the single-cell question: which component changed, is it stuck on or off, and what happens downstream?

Apply It: Predicting Altered Responses 🔬

Stuck On or Stuck Off? 🔍

Cell Communication: Problem-Solving Workshop

Part 6 of 7 — Problem-Solving Workshop

AP signaling questions rarely ask you to recite a pathway. They hand you an experiment and ask you to locate a defect, identify a control, or predict and justify a result. This workshop practices those moves on three data sets.

A four-step method for any pathway problem

1. Draw the chain. Write the pathway as boxes: ligand → receptor → relay(s) → second messenger → kinase → target → response.
2. Mark what was measured. Circle the step(s) the data actually report (for example, cAMP level or glucose output).
3. Locate the break. A defect lies after the last step that still behaves normally and at or before the first step that does not.
4. Justify with direction. State whether the altered part is stuck on or stuck off, then predict every step downstream.

Data set 1: where is the receptor, and what carries the signal?

Liver cells are broken open and separated into a membrane fraction and a cytoplasm fraction (which contains glycogen and glycogen phosphorylase). Tubes are set up and enzyme activity is measured.

Worked reasoning.

• Tubes 1 vs 2: epinephrine works only when membranes are present, so the receptor is in the membrane.
• Tubes 2 vs 3: membranes alone do not activate the enzyme, so the hormone, not some membrane component, is the trigger. Tube 3 is the negative control for tube 2.
• Tube 4: cAMP activates the enzyme with no membrane or hormone, so cAMP acts downstream of the receptor: it is the second messenger.
• Tube 5: no activity because the enzyme and glycogen are in the cytoplasm fraction, which is missing. The response requires the target.

Check Your Reasoning: Data Set 1 🎯

Data set 2: locating the defect in mutant cells

Three mutant liver cell lines and normal cells are given epinephrine. cAMP and glucose release are measured 5 minutes after the hormone is added and again 30 minutes after it is washed away.

Worked reasoning with the four-step method.

• Mutant A: nothing downstream responds, not even cAMP. The break is at or before the enzyme that makes cAMP: the receptor, the G protein or that enzyme is stuck off. More data would be needed to tell which.
• Mutant B: responds normally but cannot shut off. Something that ends the signal is missing, for example a G protein that cannot hydrolyze GTP, or a missing enzyme for breaking down cAMP. This is a stuck-on defect.
• Mutant C: cAMP rises normally, but glucose is not released. Every step through cAMP works, so the defect is after cAMP: in one of the kinases of the cascade or in the glycogen-breaking enzyme itself.

📝 AP Connection: Notice the language: "the defect lies downstream of cAMP because cAMP rises normally but glucose release does not." AP scoring rewards a claim tied to a specific piece of evidence.

Check Your Reasoning: Data Set 2 🔬

Data set 3: dose and response

Heart cells are exposed to increasing concentrations of a hormone, and the rate of contraction is measured as a percent of the maximum.

Reading the curve.

• Without the drug, the response rises steeply and then levels off near 100%. At high concentrations nearly every receptor is occupied, so adding more hormone cannot increase the response: the receptors are saturated.
• With drug X, more hormone is needed to reach the same response, but at very high hormone concentration the response still reaches nearly 100%. That pattern fits a drug that competes with the hormone for the binding site (a competitive antagonist): enough hormone can outcompete it.

FRQ-style model answer. Identify the independent variable, and describe the effect of drug X.

The independent variable is the hormone concentration. Drug X reduces the response at low and moderate hormone concentrations (for example, from 80% to 40% at 10 nM) but not at saturating concentrations (99% at 1000 nM), consistent with the drug competing with the hormone for the receptor.

Calculate from Data Set 3 🧮

1) At 10 nM hormone, by how many percentage points does drug X lower the response? 2) Without the drug, what is the response at 1 nM as a fraction of the response at 10 nM? Give a decimal to two places.

Locate the Break 🔍

For each result, choose where the defect most likely lies.

Cell Communication: Synthesis & AP Review

Part 7 of 7 — Synthesis & AP Review

This part pulls Parts 1–6 into one picture. Read the map, check yourself against the trap list, then work the mixed questions.

The topic on one page

Two pathways side by side

The six traps that cost the most points

1. "The ligand enters the cell and does the work." Most ligands never cross the membrane. The receptor's shape change starts everything.
2. "Cells without a response lack the hormone." They lack the receptor (or the downstream proteins).
3. "Signals change DNA." Signals change which genes are expressed, not the DNA sequence.
4. "A mutation affects the whole pathway." It affects steps downstream of the change, not those upstream.
5. Forgetting the off-switches. A pathway that cannot shut off (GTP not hydrolyzed, cAMP not broken down, phosphates not removed) keeps signaling.
6. Mixing up second messengers and ligands. cAMP is made inside the cell after reception; the ligand is the first messenger outside.

Mixed Review, Set 1 🎯

FRQ practice: a model response

Prompt (adapted, AP style). A researcher studies a growth factor that binds a membrane receptor and causes cell division. A mutant cell line divides rapidly even when no growth factor is present. (a) Identify one component of the pathway that could be altered in the mutant. (b) Predict the effect of adding a drug that blocks the growth factor's binding site on the receptor in the mutant cells. (c) Justify your prediction.

Model response.

(a) A relay protein downstream of the receptor, such as a G protein, could be locked in its active, GTP-bound form.

(b) The drug would not slow division in the mutant cells.

(c) The drug acts at reception, which is upstream of the mutant relay protein. Because the relay protein is already active without any signal from the receptor, blocking the receptor does not change the downstream steps, and the cells keep receiving a division signal.

📝 Scoring notes: Each part earns its point only if it is specific. "Something in the pathway is broken" does not earn (a); a prediction without the upstream/downstream logic does not earn (c).

Mixed Review, Set 2 🔬

Last-mile checklist

• I can classify a signal as contact, local or long-distance, with an example of each.
• I can predict a receptor's location from the ligand's chemistry and justify it.
• I can trace epinephrine → GPCR → G protein → cAMP-making enzyme → cAMP → kinase cascade → response.
• I can calculate amplification through a cascade.
• I can name four kinds of response, including apoptosis.
• I can predict the effect of a mutation or drug at any step, upstream versus downstream.
• I can read a dose-response table and spot receptor saturation.

🎯 Final takeaway: Every signaling question reduces to one chain and one rule: changes act downstream. Draw the chain, place the change, and predict forward.

Final Match 🔍